Literature DB >> 16972035

Analysis of the genetic and the corresponding antigenic variability of the VP1 3' end of ECHO virus type 11 and ECHO virus type 30.

Lamjed Bouslama1, Jawhar Gharbi, Mahjoub Aouni.   

Abstract

The enteroviruses (EV), RNA viruses belonging to the Picornaviridae family, have a high genetic variability due to the absence of the efficient proofreading and post replicative repair activities associated with the RNA polymerase. In the present work, we studied the genetic and the antigenic variability of ECHO virus types 11 (E11) and 30 (E30), which are the most isolated echoviruses serotypes in clinical and environmental samples. We established on the 3' end of the VP1 gene, consensus sequences of E11 and E30 by alignment of 67 E11 and 247 E30 published sequences in GenBank. Our results of sequences comparison showed that the majority of the mutational sites are situated on the third nucleotide of the codon. These mutations were without consequence on the antigenic sequences of the VP1 protein. Thus, E11 and E30 have a high genetic variability (1/3 of the nucleotides are variable), but a relative antigenic conservation. The analysis of the intertypic antigenic variability between E11 and E30 was obtained by the alignment of the corresponding amino acids sequences relative to the N-terminal part of the VP1 protein. Two discriminating parts were highlighted, probably representing antigenic sites for neutralisation antibodies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16972035     DOI: 10.1007/s11262-005-0057-1

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  31 in total

1.  Homotypic echoviruses share aminoterminal VP1 sequence homology applicable for typing.

Authors:  H Norder; L Bjerregaard; L O Magnius
Journal:  J Med Virol       Date:  2001-01       Impact factor: 2.327

2.  Molecular epidemiology of coxsackievirus B4 and disclosure of the correct VP1/2A(pro) cleavage site: evidence for high genomic diversity and long-term endemicity of distinct genotypes.

Authors:  M N Mulders; M Salminen; N Kalkkinen; T Hovi
Journal:  J Gen Virol       Date:  2000-03       Impact factor: 3.891

Review 3.  Structure, function and evolution of picornaviruses.

Authors:  G Stanway
Journal:  J Gen Virol       Date:  1990-11       Impact factor: 3.891

4.  Predominant enteroviral serotypes causing meningitis.

Authors:  P J Atkinson; M Sharland; H Maguire
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

Review 5.  Antigenic structure of picornaviruses.

Authors:  P D Minor
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

6.  An RNA tertiary structure in the 3' untranslated region of enteroviruses is necessary for efficient replication.

Authors:  M H Mirmomeni; P J Hughes; G Stanway
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 7.  Antibody recognition of picornaviruses and escape from neutralization: a structural view.

Authors:  M G Mateu
Journal:  Virus Res       Date:  1995-09       Impact factor: 3.303

Review 8.  A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes.

Authors:  W H Li; C I Wu; C C Luo
Journal:  Mol Biol Evol       Date:  1985-03       Impact factor: 16.240

9.  Antigenic sites of coxsackievirus A9.

Authors:  T Pulli; H Lankinen; M Roivainen; T Hyypiä
Journal:  Virology       Date:  1998-01-20       Impact factor: 3.616

10.  Molecular epidemiology and evolution of coxsackievirus A9.

Authors:  J Santti; H Harvala; L Kinnunen; T Hyypiä
Journal:  J Gen Virol       Date:  2000-05       Impact factor: 3.891

View more
  1 in total

1.  Distinct migratory pattern of naive and effector T cells through the blood-CSF barrier following Echovirus 30 infection.

Authors:  Marie Wiatr; Carolin Stump-Guthier; Daniela Latorre; Stefanie Uhlig; Christel Weiss; Jorma Ilonen; Britta Engelhardt; Hiroshi Ishikawa; Christian Schwerk; Horst Schroten; Tobias Tenenbaum; Henriette Rudolph
Journal:  J Neuroinflammation       Date:  2019-11-21       Impact factor: 8.322

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.